Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pexip Holding | 4W9 | Oct 7, 2024 | 3.19 | 0.00 |
Peyto Exploration & Development Corp. | PXK | Oct 7, 2024 | 10.72 | +0.66 |
Pfeiffer Vacuum Technology AG | PFV | Oct 7, 2024 | 153.60 | -0.26 |
Pferdewetten.de AG | EMH | Oct 7, 2024 | 6.50 | +1.56 |
PFERDEWETTEN.DE NA NEUE | EMH0 | Oct 7, 2024 | 4.70 | 0.00 |
PFIZER INC.CDR REG.S | PFEB | Oct 7, 2024 | 8.65 | +1.17 |
Pfizer, Inc. | PFE | Oct 7, 2024 | 26.63 | +2.50 |
PGE Polska Grupa Energetyczna SA | 6PG | Oct 7, 2024 | 1.60 | 0.00 |
PHARMACOLOG I UPPSALA B | P750 | Oct 7, 2024 | 0.01 | 0.00 |
Pharmamar S.A. | PMRA | Oct 7, 2024 | 46.78 | 0.00 |
Pharmanutra S.p.A. | 761 | Oct 7, 2024 | 54.10 | -0.92 |
Pharmaron Beijing Co Ltd | 17Q1 | Oct 7, 2024 | 2.86 | +38.84 |
PHARMASGP HOLDING SE O.N. | PSG | Oct 7, 2024 | 23.80 | +7.21 |
Pharmaust Ltd. | ECQ | Oct 7, 2024 | 0.11 | +21.98 |
Pharming Group N.V. - ADS, each representing 10 ordinary sha | PHG | Oct 7, 2024 | 7.30 | +3.55 |
Pharming Group NV | PHGN | Oct 7, 2024 | 0.72 | +0.63 |
PHarol SGPS SA | PTCA | Oct 7, 2024 | 0.04 | -0.46 |
Pharos Energy Plc | OCS1 | Oct 7, 2024 | 0.28 | +0.72 |
Pharvaris N.V. - Ordinary Shares | 9EN | Oct 7, 2024 | 16.10 | +1.26 |
PHASE HOLO.IMAG.PHI SK-20 | L5W | Oct 7, 2024 | 0.40 | +0.25 |
PHAXIAM THERAPEUT. EO 1,- | 2E40 | Oct 7, 2024 | 1.74 | -3.33 |
PHC Holdings Corporation | 2GY | Oct 7, 2024 | 6.40 | 0.00 |
PhenixFIN | Q29 | Oct 7, 2024 | 42.60 | +0.47 |
Phenom Resources Corp | 1PY0 | Oct 7, 2024 | 0.26 | +1.59 |
Phibro Animal Health Corporation - Class A | PB8 | Oct 7, 2024 | 19.20 | +1.59 |
Phicomm AG | HBD1 | Oct 7, 2024 | 0.78 | +30.00 |
Philion Se Bearer NPV | PH6 | Oct 7, 2024 | 0.43 | +0.47 |
Philip Morris Cr A.S. | TBK | Oct 7, 2024 | 599.00 | -0.33 |
Philip Morris International Inc | 4I1 | Oct 7, 2024 | 108.56 | +0.82 |
Philips KON | PHI1 | Oct 7, 2024 | 29.17 | -0.55 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.